Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
14.93
+0.83 (5.89%)
At close: May 12, 2025, 4:00 PM
15.40
+0.47 (3.15%)
After-hours: May 12, 2025, 7:12 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $901.08 million as of May 12, 2025. Its market cap has decreased by -24.44% in one year.
Market Cap
901.08M
Enterprise Value
336.26M
1-Year Change
-24.44%
Ranking
Category
Stock Price
$14.93
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $901.08M, an increase of 706.70%. That is a compound annual growth rate of 25.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 851.00M | -28.92% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |